Nick A. Blankl

Plus aucun poste en cours

Finance

Consumer Services

Consumer Non-Durables

Profil

Mr. Nick A. Blankl is Founder & Portfolio Manager at Compendium Capital Management LLC.
Prior to founding Compendium Capital Management in 2013, Mr. Blankl was employed as a Portfolio Manager by Roxbury Capital Management LLC, Senior Vice President by Provident Investment Counsel, Inc. and National Marketing Manager by Schwans Sales Enterprises, Inc. Mr. Blankl received his BBA from Loyola Marymount University-College of Business Administration and MBA in Finance from the University of Southern California-Marshall School of Business.
He is a Chartered Financial Analyst.

Anciens postes connus de Nick A. Blankl

Sociétés	Poste	Fin
Roxbury Capital Management LLC Roxbury Capital Management LLC Investment ManagersFinance Roxbury Capital Management offers a variety of value-added equity strategies across all market-caps. The firm's Core Equity strategy seeks long-term capital appreciation and moderate income. They invest in high quality, mostly dividend paying stocks. Roxbury employs a bottom-up approach that seeks to identify stocks with above-average earnings growth, strong financial strength, experienced and shareholder-friendly management teams, dominant business models, pricing power, the ability to prosper in a variety of markets, significant free cash flows, competitive advantages and attractive valuations. The strategy emphasizes large-cap stocks, but may also target mid-cap sticks. The portfolio typically consists of 40 to 60 stocks. The firm's Focus strategy seeks long-term capital appreciation by investing in a concentrated portfolio of quality, sustainable growth companies. The firm employs a bottom-up approach to identify stocks with above-average earnings growth, strong financial strength, dominant business models, pricing power, significant free cash flows, attractive risk/reward characteristics and the ability to prosper in a variety of market environments. Companies must have a competitive advantage that will allow it to grow returns on capital relative to the cost of capital. The portfolio typically consists of 15 to 20 stocks. Position sizes average 5%, although that weighting may vary depending on a stock's risk-reward characteristics. Roxbury's Health Sciences strategy is a non-diversified product that focuses on healthcare investments including biotechnology, medical devices, pharmaceutical and professional health services companies. They employ a bottom-up approach to identify stocks with above-average earnings and dividend growth, strong financial strength, dominant business models, pricing power, significant free cash flows and attractive risk/reward characteristics. Companies must have a competitive advantage that will allow it to grow returns on capital. Roxbury will sell a position if the risk/reward characteristics of a stock turn negative, company fundamentals deteriorate, a more attractive investment idea is identified or the stock achieves their price target. The portfolio typically consists of 20 to 40 stocks. The firm's Quantitative Strategies Group manages a series of hedge funds designed to provide above-average returns with lower volatility. The funds may short stocks and/or utilize leverage. Roxbury's Mid-Cap Value strategy seeks to combine the stability and lower volatility of investing in high quality, dividend-paying equities with the potential for capital appreciation. The firm analyzes a broad universe of mid-cap companies, evaluating companies' financial strength, earnings predictability, cash flow and valuations. Companies are typically sold when they become overvalued, more attractive investments are identified, the dividend is reduced/eliminated or if fundamentals weaken. The typically portfolio holds 35 to 60 stocks with market-caps averaging below $10 billion. Individual positions are limited to 5% of the portfolio at cost. Roxbury's Small-Cap Growth strategy seeks long-term capital appreciation by investing in stocks with market-caps below $2 billion that have strong growth characteristics and attractive pricing relative to underlying profitability. The process begins by screening a universe of stocks with future expected earnings growth of greater than 15%. The firm then performs fundamental analysis to identify companies with growing revenues, stable or expanding margins, emerging industry leadership positions, low debt levels, solid cash flows and high or potentially high returns on capital. Further research is performed to identify companies with dominant competitive positions, positive business and market trends and strong management teams. Companies become a purchase candidate only if the firm believes there is a catalyst in place to provide for at least 15% stock price appreciation over the next 12 months. The Small-Cap Growth strategy typically holds 60 to 90 stocks. Individual stock positions are limited to a maximum of 5% and sector concentrations can't be more than 15% different than the weightings in the Russell 2000 Growth Index. The firm's Small/Mid-Cap strategy seeks long-term capital appreciation by investing in high quality small- to mid-cap companies with sustainable growth that are trading at attractive valuations. Roxbury looks for companies with favorable competitive positions, strong financials and a commitment to enhancing shareholder value. Companies typically have seasoned operations that can continue to grow in a variety of market environments and are run by experienced management teams. Companies should also have proprietary technologies, free cash flow generation, low cost production and high barriers to entry. Roxbury looks for stocks capable of growing earnings on a sustainable basis of 15% or more annually. The investment process is designed to produce a portfolio of relatively predictable companies with above average growth rates, strong financial strength and high returns on equity. The portfolio typically consists of 35 to 60 stocks with position sizes ranging from 1% to 5% at cost. Roxbury's Strategic Growth strategy seeks to grow client capital by investing in durable large-cap franchises with the potential to grow excess returns on capital that are trading at a significant discount to their estimate of the company's true value. They employ a bottom-up approach that seeks to identify growth companies with sustainable competitive advantages and opportunities to grow and reinvest capital at high rates of return. Roxbury looks for companies with attractive unit growth opportunities, strong pricing power, dominant or rapidly growing market shares, sustainable or expanding profit margins, well-capitalized balance sheets and consistent excess free cash flows. The portfolio typically consists of 30 to 50 stocks. Position sizes range from 1% to 5% at cost.	Analyst-Equity	21/09/2010
300 North Capital LLC 300 North Capital LLC Investment ManagersFinance 300 North Capital (300NC) specializes in long-only small-cap, small to mid-cap (SMID) and mid-cap growth equity strategies. The firm also manages accounts and funds with a global macro strategy. 300NC’s investment approach for small cap, mid-cap, and SMID-cap strategies focuses primarily on fundamental, bottom-up research. In addition, they overlay a top-down strategic outlook. Their equity universe consists of U.S. companies, ADRs, and relevant U.S. traded foreign companies with market-cap in the range of the relative Russell growth index. 300NC’s global macro product is a variable biased global macro strategy that primarily invests in equities, fixed income securities, commodities, and currencies. The strategy holds only listed, liquid securities, and maintains a gross invested position generally between 0% and 200% and net exposure generally between -100% and +200%, in normal capital market environments.	Analyst-Equity	29/09/2008
Schwan's Shared Services LLC Schwan's Shared Services LLC Food: Specialty/CandyConsumer Non-Durables Manufactures and markets frozen foods	Sales & Marketing	-
Compendium Capital Management LLC Compendium Capital Management LLC Investment ManagersFinance Profile Unavailable	Fondateur	-

Voir l'expérience en détail de Nick A. Blankl

Formation de Nick A. Blankl

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Nick A. Blankl

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	6
300 North Capital LLC 300 North Capital LLC Investment ManagersFinance 300 North Capital (300NC) specializes in long-only small-cap, small to mid-cap (SMID) and mid-cap growth equity strategies. The firm also manages accounts and funds with a global macro strategy. 300NC’s investment approach for small cap, mid-cap, and SMID-cap strategies focuses primarily on fundamental, bottom-up research. In addition, they overlay a top-down strategic outlook. Their equity universe consists of U.S. companies, ADRs, and relevant U.S. traded foreign companies with market-cap in the range of the relative Russell growth index. 300NC’s global macro product is a variable biased global macro strategy that primarily invests in equities, fixed income securities, commodities, and currencies. The strategy holds only listed, liquid securities, and maintains a gross invested position generally between 0% and 200% and net exposure generally between -100% and +200%, in normal capital market environments.	Finance
Roxbury Capital Management LLC Roxbury Capital Management LLC Investment ManagersFinance Roxbury Capital Management offers a variety of value-added equity strategies across all market-caps. The firm's Core Equity strategy seeks long-term capital appreciation and moderate income. They invest in high quality, mostly dividend paying stocks. Roxbury employs a bottom-up approach that seeks to identify stocks with above-average earnings growth, strong financial strength, experienced and shareholder-friendly management teams, dominant business models, pricing power, the ability to prosper in a variety of markets, significant free cash flows, competitive advantages and attractive valuations. The strategy emphasizes large-cap stocks, but may also target mid-cap sticks. The portfolio typically consists of 40 to 60 stocks. The firm's Focus strategy seeks long-term capital appreciation by investing in a concentrated portfolio of quality, sustainable growth companies. The firm employs a bottom-up approach to identify stocks with above-average earnings growth, strong financial strength, dominant business models, pricing power, significant free cash flows, attractive risk/reward characteristics and the ability to prosper in a variety of market environments. Companies must have a competitive advantage that will allow it to grow returns on capital relative to the cost of capital. The portfolio typically consists of 15 to 20 stocks. Position sizes average 5%, although that weighting may vary depending on a stock's risk-reward characteristics. Roxbury's Health Sciences strategy is a non-diversified product that focuses on healthcare investments including biotechnology, medical devices, pharmaceutical and professional health services companies. They employ a bottom-up approach to identify stocks with above-average earnings and dividend growth, strong financial strength, dominant business models, pricing power, significant free cash flows and attractive risk/reward characteristics. Companies must have a competitive advantage that will allow it to grow returns on capital. Roxbury will sell a position if the risk/reward characteristics of a stock turn negative, company fundamentals deteriorate, a more attractive investment idea is identified or the stock achieves their price target. The portfolio typically consists of 20 to 40 stocks. The firm's Quantitative Strategies Group manages a series of hedge funds designed to provide above-average returns with lower volatility. The funds may short stocks and/or utilize leverage. Roxbury's Mid-Cap Value strategy seeks to combine the stability and lower volatility of investing in high quality, dividend-paying equities with the potential for capital appreciation. The firm analyzes a broad universe of mid-cap companies, evaluating companies' financial strength, earnings predictability, cash flow and valuations. Companies are typically sold when they become overvalued, more attractive investments are identified, the dividend is reduced/eliminated or if fundamentals weaken. The typically portfolio holds 35 to 60 stocks with market-caps averaging below $10 billion. Individual positions are limited to 5% of the portfolio at cost. Roxbury's Small-Cap Growth strategy seeks long-term capital appreciation by investing in stocks with market-caps below $2 billion that have strong growth characteristics and attractive pricing relative to underlying profitability. The process begins by screening a universe of stocks with future expected earnings growth of greater than 15%. The firm then performs fundamental analysis to identify companies with growing revenues, stable or expanding margins, emerging industry leadership positions, low debt levels, solid cash flows and high or potentially high returns on capital. Further research is performed to identify companies with dominant competitive positions, positive business and market trends and strong management teams. Companies become a purchase candidate only if the firm believes there is a catalyst in place to provide for at least 15% stock price appreciation over the next 12 months. The Small-Cap Growth strategy typically holds 60 to 90 stocks. Individual stock positions are limited to a maximum of 5% and sector concentrations can't be more than 15% different than the weightings in the Russell 2000 Growth Index. The firm's Small/Mid-Cap strategy seeks long-term capital appreciation by investing in high quality small- to mid-cap companies with sustainable growth that are trading at attractive valuations. Roxbury looks for companies with favorable competitive positions, strong financials and a commitment to enhancing shareholder value. Companies typically have seasoned operations that can continue to grow in a variety of market environments and are run by experienced management teams. Companies should also have proprietary technologies, free cash flow generation, low cost production and high barriers to entry. Roxbury looks for stocks capable of growing earnings on a sustainable basis of 15% or more annually. The investment process is designed to produce a portfolio of relatively predictable companies with above average growth rates, strong financial strength and high returns on equity. The portfolio typically consists of 35 to 60 stocks with position sizes ranging from 1% to 5% at cost. Roxbury's Strategic Growth strategy seeks to grow client capital by investing in durable large-cap franchises with the potential to grow excess returns on capital that are trading at a significant discount to their estimate of the company's true value. They employ a bottom-up approach that seeks to identify growth companies with sustainable competitive advantages and opportunities to grow and reinvest capital at high rates of return. Roxbury looks for companies with attractive unit growth opportunities, strong pricing power, dominant or rapidly growing market shares, sustainable or expanding profit margins, well-capitalized balance sheets and consistent excess free cash flows. The portfolio typically consists of 30 to 50 stocks. Position sizes range from 1% to 5% at cost.	Finance
University of Southern California University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Schwan's Shared Services LLC Schwan's Shared Services LLC Food: Specialty/CandyConsumer Non-Durables Manufactures and markets frozen foods	Consumer Non-Durables
Loyola Marymount University Loyola Marymount University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Compendium Capital Management LLC Compendium Capital Management LLC Investment ManagersFinance Profile Unavailable	Finance